Chamomile: An anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity

Abstract

Chamomile has long been used in traditional medicine for the treatment of inflammation-related disorders. In this study we investigated the inhibitory effects of chamomile on nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression, and explored its potential anti-inflammatory mechanisms using RAW 264.7 macrophages. Chamomile treatment inhibited LPS-induced NO production and significantly blocked IL-1β, IL-6 and TNFα-induced NO levels in RAW 264.7 macrophages. Chamomile caused reduction in LPS-induced iNOS mRNA and protein expression. In RAW 264.7 macrophages, LPS-induced DNA binding activity of RelA/p65 was significantly inhibited by chamomile, an effect that was mediated through the inhibition of IKKβ, the upstream kinase regulating NF-κB/Rel activity, and degradation of inhibitory factor-κB. These results demonstrate that chamomile inhibits NO production and iNOS gene expression by inhibiting RelA/p65 activation and supports the utilization of chamomile as an effective anti-inflammatory agent.

Full text

Chamomile, an anti-inflammatory agent inhibits inducible nitric
oxide synthase expression by blocking RelA/p65 activity
Natarajan Bhaskaran1,2, Sanjeev Shukla1,2, Janmejai K Srivastava3, and Sanjay Gupta1,2,4
1 Department of Urology, Case Western Reserve University, Cleveland, Ohio 44106
2 University Hospitals Case Medical Center, Cleveland, Ohio 44106
3 Institute of Biotechnology, Amity University, Lucknow Campus, Lucknow, India
4 Case Comprehensive Cancer Center, Cleveland, Ohio 44106
Abstract
Chamomile has long been used in traditional medicine for the treatment of inflammation-related
disorders. In this study we aimed to investigate the inhibitory effects of chamomile on nitric oxide
(NO) production and inducible nitric oxide synthase (iNOS) expression, and to explore its potential
anti-inflammatory mechanisms using RAW 264.7 macrophages. Chamomile treatment inhibited
LPS-induced NO production and significantly blocked IL-1β , IL-6 and TNFα-induced NO levels in
RAW 264.7 macrophages. Chamomile caused reduction in LPS-induced iNOS mRNA and protein
expression. In RAW 264.7 macrophages, LPS-induced DNA binding activity of RelA/p65 was
significantly inhibited by chamomile, an effect that was mediated through the inhibition of IKKβ ,
the upstream kinase regulating NF-κ B/Rel activity, and degradation of inhibitory factor-κ B. These
results demonstrate that chamomile inhibits NO production and iNOS gene expression by inhibiting
RelA/p65 activation and supports the utilization of chamomile as an effective anti-inflammatory
agent.
Keywords
inflammation; nitric oxide; chamomile; nuclear factor-κ B; macrophages; pro-inflammatory
cytokines
INTRODUCTION
Chronic inflammation of longstanding duration plays a critical role in the initiation and
development of various human diseases including cancer [1]. Macrophages play a central role
in the inflammatory response and produce excess amounts of pro-inflammatory cytokines, pro-
inflammatory enzymes and inflammatory mediators, the accumulation of which leads to
disease development [2,3]. Activated macrophages transcriptionally express inducible nitric
oxide synthase (iNOS), which catalyzes the oxidative deamination of L-arginine to produce
nitric oxide (NO), and is responsible for prolonged and profound production of NO [4]. High
output of NO by iNOS induces deleterious effects such as inflammation and cancer [5,6].
Molecular cloning and sequencing analysis studies have demonstrated the existence of at least
3 main types of NOS isoforms, endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible
*Correspondence to: Sanjay Gupta, Ph.D., Department of Urology, Case Western Reserve University, University Hospitals Case Medical
Center, 10900 Euclid Avenue, Cleveland, Ohio 44106, Phone: (216) 368 6162, Fax: (216) 368 0213, sanjay.gupta@case.edu.
NIH Public Access
Author Manuscript
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as:
Int J Mol Med. 2010 December ; 26(6): 935–940.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

NOS (iNOS) [7]. Expression of the iNOS gene is regulated at the transcriptional level by the
NF-κ B/Rel family of transcription factors, which are involved in regulation of immune and
inflammatory responses. The murine iNOS promoter contains two NF-κ B/Rel binding sites
located at 55 and 971 base pairs upstream of the TATA box. Moreover, it has been reported
that the protein binding to both of these–κ B sites is necessary for the full induction of the iNOS
gene by pro-inflammatory mediators such as lipopolysaccharide [8,9]. In un-stimulated cells,
NF-κ B/Rel exists in an inactive state in the cytoplasm, complexed with an inhibitory protein
called Iκ B. Upon activation, Iκ B undergoes phosphorylation and degradation and the NF-κ
B/Rel heterodimer is translocated into the nucleus where it binds to DNA and activates
transcription [10]. A number of inflammatory stimuli and pro-inflammatory cytokines activate
immune cells to upregulate inflammation, and consequently are potential targets for
exploration of the molecular mechanisms underlying the activation processes, with the aim of
developing effective anti-inflammatory drugs to ameliorate their untoward effects.
Chamomile is an herbal plant that has been used for centuries in many human cultures to treat
various inflammatory conditions such as eczema, ulcers, gout, neuralgia and rheumatic pains
[11,12]. Dried flowers of Matricaria chamomilla L. are used in the preparation of tea, which
is consumed at a rate of more than a million cups per day [13]. The beneficial effects of
chamomile are related to the presence of several flavonoid constituents and the core structure
consists of either flavone (apigenin, luteolin) or flavonol-derivatives (quercetin, patuletin).
These occur in various forms such as aglyco- mono- and di-glycosides and/or acyl-derivatives.
Other principal components are essential oils such as terpenoids, α-bisabolol and its oxides,
azulenes including chalmuzene and acetylene derivatives [14].
Chamomile has been approved by the German Commission E for oral consumption in the
management of various inflammatory diseases of the gastrointestinal tract, and for topical
application in the treatment of various skin disorders and inflammatory disorders of certain
mucosal surfaces, such as the oral cavity and ano-genital areas [15]. Recent studies have
demonstrated its antioxidant, hypocholesterolemic, anti-parasitic, anti-aging, and anticancer
properties, supporting its longstanding traditional use for treating various human ailments
[16–18]. In previous investigations, we have demonstrated that chamomile is a selective
COX-2 inhibitor with anti-inflammatory activities [19]. In the current study, we investigated
the effects of chamomile on NO synthesis in LPS activated macrophages and analyzed the
underlying mechanisms of action using RAW 264.7 murine macrophages.
MATERIALS AND METHODS
Materials
Dry chamomile flower of Egyptian origin was purchased from Bec's Tea Nirvana, Cleveland,
Ohio. Cell culture medium, DMEM, fetal bovine serum, penicillin–streptomycin cocktail and
phosphate buffered saline were purchased from Cellgro Mediatech, Inc. (Herndon, VA).
Lipopolysaccharide (LPS, E coli), and apigenin 7-O-glucoside (>95% pure) were purchased
from Sigma (St. Louis, MO). Mouse rTNF- α , mouse rIL-6, and mouse rIL-1β were purchased
from R&D Systems (Minneapolis, MN). L-NMMA NG-monomethyl-L-arginine, monoacetate
salt was purchased from Calbiochem (Brookfield, WI). All reagents used in the experiments
were of analytical reagent grade or HPLC grade where applicable.
Preparation of extracts
Dry chamomile flowers were weighed and crushed to powder with a marble pestle and mortar
and a 5% w/v suspension was prepared in a flask by adding hot boiled water. The flask was
then placed on a shaker (200 rpm) for 4 h and the temperature was maintained at 37°C. After
shaking, the flask was brought to room temperature and the suspension was filtered through a
Bhaskaran et al. Page 2
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

series of Whatman filters and finally passed through 0.22 micron filter (Millipore, Billerica,
MA). The filtered aqueous extract was freeze-dried and stored at −20°C until use. For cell
culture studies, the dried material from aqueous extract was weighed and dissolved in culture
medium to achieve desired concentration.
Cell culture
Murine RAW 264.7 macrophages were obtained from the American Type Culture Collection
(ATCC) and cultured in Dulbecco's modified essential medium in appropriate culture
conditions. Cell stimulation was performed with 1 μg/mL of LPS, mouse rTNF-α , mouse rIL-6,
and mouse rIL-1β .
Cell viability assay
Cell respiration, an indicator of cell viability, was determined by the mitochondrial-dependent
reduction of 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to
formazan. After the supernatants were removed for nitrite assay, cells were incubated at 37°
with MTT (0.5 mg/mL) for 45 min. The medium was aspirated and cells were solubilized in
dimethyl sulfoxide (250 μL) for at least 2 h in the dark. The extent of reduction of MTT was
quantified by optical density measurement at 550 nm.
Nitrite estimation
RAW 264.7 macrophages were cultured in 6 well plates. After incubation with LPS and other
cytokines and various doses of chamomile for 12–24 h, nitric oxide synthesis was determined
by assaying the culture medium for nitrite, which is the stable reaction product of nitric oxide
with molecular oxygen, using Griess reagent kit obtained from Biotium (Hayward, CA).
Western blot analysis
Macrophages, grown in 6-well plates to confluence, were incubated with or without LPS in
the absence or presence of the test agents for 16 h. Cells were washed with ice-cold PBS and
stored at 70° until further analysis. Frozen plates were put on ice and cells were lysed in 1%
Triton X-100, 0.15 M NaCl, and 10 mM Tris-HCl pH 7.4 for 30 min. Lysates were
homogenized through a 22 G needle and centrifuged at 10,000 g for 10 min at 4°. The
supernatants were collected and protein was measured by the method according to Bradford,
1976 [20]. Cell lysates, containing equal amounts of protein, were boiled in SDS sample buffer
for 5 min before running on a 10% SDS–polyacrylamide gel. Proteins were transferred to
polyvinylidene fluoride membranes (Invitrogen, Carlsbad, CA). Membranes were blocked
with 5% fat-free dry milk in TBS-T pH 8.0 (Tris-buffered saline [50 mM Tris, pH 8.0, 150
mM NaCl] with 0.1% Tween 20) and then incubated with antibodies viz. anti-iNOS (SC-7271),
anti-Iκ Bα (SC- 1643), anti-NF-κ B/RelA (SC-8008) anti-β-actin (SC-47778) obtained from
SantaCruz (SantaCruz, CA), anti-p-IKKα /IKKβ (Ser180/181; Cat#2681), anti-p-Iκ Bα
(Ser32/36; Cat#9246) obtained from Cell Signaling Technology (Beverly, MA) with
appropriate dilutions and incubated overnight at 4°C. After washing 3 times with TBS-T, and
the bands were visualized by using appropriate IgG:horseradish peroxidase conjugate and the
enhanced chemiluminescence system (ECL , Amersham Pharmacia Biotech). Signal intensities
were evaluated by densitometric analysis (Kodak Digital Science Image Station 2000R Life
Science Products).
Reverse transcriptase (RT)-PCR analysis
RAW 264.7 cells (5 × 106 cells-100 mm dish) were incubated for 8 h with or without various
concentrations of chamomile and LPS (1 μg/ml). After washing with PBS twice, total RNA
was isolated from the cell pellet using RNA isolation kit (Invitrogen, CA). The total amount
of RNA was determined by absorbance at 260 nm. One microgram (μg) of RNA was reverse
Bhaskaran et al. Page 3
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

transcribed into cDNA using avian myeloblastosis virus (AMV) reverse transcriptase and oligo
(dT)15 primer (Promega Co., Madison, WI, USA). The PCR samples contained 50 μl of the
reaction mixture, comprised of 50 mM KCl, 5 mM MgCl2, 0.16 mM dNTP, 5.0 units of Taq
DNA polymerase (Qiagen, Valencia, CA, USA), and 20 pmol of sense and antisense primers
in 10 mM Tris-HCl (pH 8.3). The primer for iNOS were 5’-
CAGTTCTGCGCCTTTGCTCAT-3’ (sense) and 5’-
GGTGGTGCGGCTGGACTTT-3’ (antisense), and those for GAPDH 5’-
AGGCCGGTGCTGAGTATGTC-3’ (sense) and 5’-
TGCCTGCTTCACCACCTTCT-3’ (antisense). The PCR amplification was performed under
the following conditions: 30 cycles of denaturation at 98°C for 30 sec, annealing at 60°C for
30 sec and extension at 74 °C for 1 min, using a thermal cycler (Px2, Thermo Electron
Corporation). The amplified PCR products were run on a 2% agarose gel and visualized by
SYBR Gold staining.
Electrophoretic mobility shift assay (EMSA)
EMSA for NF-κ B was performed in the nuclear fraction of RAW 264.7 macrophages incubated
for 16 h with or without various concentrations of chamomile and LPS (1 μg/ml) using
LightshiftTM Chemiluminiscent EMSA kit (Pierce Biotechnology, Rockford, IL) following
manufacturer’s protocol as previously described [21].
Statistical analysis
Nitrite estimation and cell viability were performed in triplicate. All experiments were repeated
at least twice. Results are expressed as mean values ± SEM. Statistical comparisons were made
by ANOVA followed by a Dunnett's multiple comparison test. P values < 0.05 were considered
significant.
RESULTS
First, we performed HPLC analysis on aqueous chamomile extract with reference to apigenin
7-O-glucoside, the major constituent of chamomile. As shown in figure 1A, HPLC analysis
demonstrated two major peaks with retention times of 1.179 min (27.7%) and 1.520 min
(63.3%) and 5 other minor peaks which together constitute 90% of the total flavonoids. The
two major peaks in the aqueous chamomile extract correspond to apigenin 7-O-glucoside
(63.3%) and apigenin 7-O-neohesperidoside (27.7%), which was further confirmed by LC-MS
analysis as previously demonstrated [12].
Next we standardized aqueous chamomile extract with doses equivalent to molar concentration
of apigenin 7-O-glucoside. For this study, different concentration of apigenin 7-O-glucoside
were prepared in methanol and subjected to HPLC (Figure 1A). The peak area (retention time
1.5 to 1.7 min) were calculated and plotted to obtain a standard curve, which corresponded to
the concentration of apigenin 7-O-glucoside in the aqueous extract on the basis of peak area
(Figure 1B).
Following this, we determined the effect of aqueous chamomile extract on inhibition of
constitutive NOS expression in RAW 264.7 cells by measuring the levels of total nitrite. The
amount of nitrite, a stable metabolite of NO in the cell culture medium was estimated using
Griess reagent as an index for nitric oxide. RAW 264.7 macrophages in the un-stimulated state
produced 0.98 + 0.01 μM nitrite in the medium. Treatment of macrophages with chamomile
cause a modest decrease in the endogenous NO levels in RAW 264.7 cells which was more
pronounced at 20- and 40-μg/mL doses of chamomile (Figure 1C). Chamomile exposure did
not affect cell viability at the test concentration up to 40-μg/mL. At 80-μg/mL chamomile, a
modest decrease in cell viability was observed.
Bhaskaran et al. Page 4
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Since IL-1β , IL-6 and TNFα are known pro-inflammatory cytokines and LPS causes NO
production, we examined whether chamomile is capable of inhibiting NO levels after challenge
with these pro-inflammatory mediators. As shown in figure 2A-D, chamomile at 10- and 20-
μg/mL doses significantly blocked NO production after challenge of RAW 264.7 cells with
these molecules up to 40–60%. Since the NO production was highest with LPS challenge,
therefore for further experiments we used LPS (1μg/mL).
Next we performed time course experiments to determine the decrease in levels of NO by
chamomile. As shown in figure 3A, treatment of RAW 264.7 cells with 10-μg/mL for 3 h to
48 h caused a significant decrease in NO production in the culture medium by 16.6% starting
as early as 3 h and 79.8% at 48 h, respectively. In dose-dependent assay, treatment of RAW
264.7 macrophages with LPS for 24 h, the nitrite concentration in the culture medium increased
to about 30-fold. Treatment with chamomile caused a significant decrease in NO production
with 53.3% at 5-μg/mL to 83.3% at the highest dose of 40-μg/mL, respectively. However, a
decrease of 23.3% in NO production was achieved after treatment of RAW 264.7 macrophages
with L-NMMA, a non-selective inhibitor of all NOS isoforms (Figure 4B).
The marked reduction in nitrite production with chamomile suggests that it might also affect
the iNOS protein expression. Therefore, we examined iNOS protein expression by Western
Blot analysis. As shown in Figure 4A, RAW 264.7 macrophages incubated with LPS (1μg/
mL) in the absence and presence of chamomile at 10–40 μg/mL concentration for 16 h and the
cell extract were examined for 133 KDa iNOS protein. As shown in figure 4A, reduced iNOS
protein expression were observed after chamomile treatment compared to LPS alone challenge,
which was dose-dependent. At the message level, chamomile treatment to LPS challenged
RAW 264.7 macrophages resulted in a modest decrease in mRNA expression (Figure 4B).
Since LPS-mediated activation of NF-κ B is associated with prolonged activation of IKK, the
upstream kinase, we first sought to determine whether chamomile can alter the level of this
kinase. As shown in figure 5A, LPS challenge to RAW 264.7 macrophages resulted in a
significant increase in phosphorylation of IKKα /β which was markedly reduced with
chamomile treatment in dose-dependent manner. Activation of IKK leads to the hyper-
phosphorylation of Iκ Bα as well as its subsequent degradation therefore next we measured the
cytosolic levels of Iκ Bα and its phosphorylated forms. Treatment with chamomile resulted in
an increase in the total levels of Iκ Bα in the cytosol whereas a significant decrease in the p-
Iκ Bα at Serine 32/36 was observed after chamomile treatment which was dose-dependent.
Furthermore, treatment of RAW 264.7 cells with chamomile caused a decrease in the nuclear
levels of NF-κ B/p65 which correlated with a simultaneous increase in the cytosol in dose-
dependent manner (Figure 5B).
To further confirm NF-κ B-mediated iNOS gene regulation, an EMSA was performed using
an oligonucleotide containing a consensus RelA/p65 binding sequence in the nuclear fractions
prepared after LPS challenge and chamomile treatment. A strong NF-κ B band was observed
in response to LPS- induced activation which was reduced with chamomile treatment (Figure
5C). These results demonstrate that chamomile blocked NF-κ B activation, which might
account for the inhibition of iNOS induction in RAW 264.7 macrophages.
DISCUSSION
Chamomile is known to possess anti-inflammatory and antioxidant effects. In the present study,
we demonstrated that chamomile inhibits NO production and iNOS expression in
macrophages, and showed that these effects are mediated through the inhibition of NF-κ B/Rel
transcription factor. As stated earlier NO plays an important role in the pathogenesis of various
inflammatory diseases, including cancer. Therefore, the inhibitory effect of chamomile on
Bhaskaran et al. Page 5
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

iNOS gene expression suggests that this is one of the mechanisms responsible for its anti-
inflammatory properties.
Macrophages play a central role in a host’s defense against various infections by nature of their
phagocytic, cytotoxic, and intracellular killing capacities [22]. Stimulation of murine
macrophages by LPS, the major component of Gram-negative bacterial cell walls, results in
expression of iNOS [23]. Increased production of NO plays a critical role in the process of
macrophage activation and is associated with acute and chronic inflammations [24]. Therefore,
the suppression of NO production by inhibition of iNOS expression and/or enzyme activity is
potentially a very important therapeutic strategy in the development of therapeutic anti-
inflammatory agents. In the current study, we have demonstrated that chamomile inhibits LPS-
induced NO production in RAW 264.7 macrophages. The inhibitory effect of chamomile was
mediated via a reduction in iNOS both at the protein and message levels.
Macrophages are capable of secreting various mediators such as IL-1, IL-6, granulocyte-
macrophage colony-stimulating factor (GM-CSF) and TNFα , which lead to secondary immune
responses such as proliferation of T and B cells, activation of macrophages for phagocytosis,
and killing of microorganisms. Among these mediators, pro-inflammatory cytokines such as
IL-1β , IL-6 and TNFα can be generated in response to immunological reaction, inflammation
and microbial invasion [25]. Therefore, we sought to examine whether chamomile could alter
NO production after incubation of RAW 264.7 macrophages with these cytokines along with
chamomile. Our results demonstrate that chamomile may, in part, exert inhibitory effects on
pro-inflammatory cytokines through inhibition of NO production in RAW 264.7 macrophages.
NO production by iNOS is regulated mainly at the transcriptional level, and the expression of
the iNOS gene in macrophages is under the control of several transcription factors, which
include NF- κ B/RelA [26]. The cis-acting NF-κ B element's presence has been demonstrated
in the 5′ flanking regions of both the COX-2 and iNOS genes [27,28]. Recently we have
demonstrated that chamomile differentially inhibits LPS-induced COX-2 activity and
expression in RAW 264.7 macrophages [19]. NF-κ B is functional as a hetero- or homo-dimeric
form of the Rel family proteins, including RelA (p65), RelB, cRel, p50 and p52 [29. In resting
cells, cytoplasmic Iκ B proteins (Iκ Bα , Iκ Bβ , and Iκ Bε) are associated with NF-κ B dimmers,
and some stimuli, such as IL-1β and LPS, lead to prolonged activation of IKK, the upstream
kinase regulating NF-κ B [30]. Our studies demonstrate that chamomile in a dose-dependent
manner suppresses LPS-mediated IKK expression, NF-κ B activation and its translocation to
the nucleus. These results suggest that chamomile inhibits the expression of iNOS and thus
NO production, a process that is mediated through inactivation of NF-κ B by reducing Iκ Bα
degradation and phosphorylation.
It is well known that RelA/p65 is a critical transactivation subunit for NF-κ B [31,32]. Our
studies performed through EMSA demonstrate that chamomile inhibits RelA/p65 activation.
Moreover, recent studies have demonstrated that the transcriptional activity of RelA/p65
subunit is regulated by posttranslational modifications such as phosphorylation and acetylation
[33]. It has been shown that the phosphorylation status of RelA determines whether it associates
with CREB-binding protein/p300, which is a critical regulator of NF-κ B [34]. In this regard,
it is possible that chamomile suppresses transcriptional activity of RelA/p65 by modifying the
phosphorylation or acetylation status of the RelA/p65 subunit. Further studies are required to
understand as how chamomile regulates the transcriptional activity of the RelA/p65 subunit.
In summary, this study demonstrates that chamomile inhibits LPS-induced NO production and
iNOS gene expression in macrophages and that these effects are mediated, at least in part,
through blockage of NF-κ B/Rel transcriptional activation. The fact that NF-κ B/Rel is
negatively regulated by chamomile is important, because this transcription factor plays a
Bhaskaran et al. Page 6
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

critical role in the regulation of a variety of genes that are involved in inflammatory responses.
Since chamomile is a nontoxic and pharmacologically active compound that has demonstrable
inhibitory effects on iNOS gene expression, and since NO plays an important role in mediating
inflammatory responses, our study supports the utilization of chamomile as a potentially
effective therapeutic anti-inflammatory agent.
Acknowledgments
Financial Support: This work was supported by grants from United States Public Health Services RO1 AT002709 and
RO1 CA108512
Abbreviations
EMSA electrophoretic mobility shift assay
GM-CSF granulocyte-macrophage colony-stimulating factor
HPLC high performance liquid chromatography
NO nitric oxide
NOS nitric oxide synthase
IL-1βinterleukin 1beta
TNFαtumor necrosis factor-alpha
LPS lipopolysaccharide
NF-κ B nuclear factor-κ appaB
IKK Iκ appaB kinase
References
1. Fujihara M, Muroi M, Tanamoto K, et al. Molecular mechanisms of macrophage activation and
deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 2003;100:171–
194. [PubMed: 14609719]
2. Ahn KS, Noh EJ, Zhao HL, et al. Inhibition of inducible nitric oxide synthase and cyclooxygenase II
by platycodon grandiflorum saponins via suppression of nuclear factor-kappa B activation in RAW
264.7 cells. Life Sci 2005;76:2315–2328. [PubMed: 15748625]
3. Makarov SS. NF-kappa B as a therapeutic target in chronic inflammation: recent advances. Molecular
Medicine Today 2000;6:441–448. [PubMed: 11074370]
4. Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol
1994;56:576–582. [PubMed: 7525816]
5. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta 1999;1411:437–455. [PubMed:
10320674]
6. Zamora R, Vodovotz Y, Billiar TR. Inducible nitric oxide synthase and inflammatory diseases. Mol
Med 2000;6:347–373. [PubMed: 10952018]
7. Noh EJ, Ahn KS, Shin EM, Jung SH, Kim YS. Inhibition of lipopolysaccharide-induced iNOS and
COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7
macrophages. Life Sci 2006;79:695–701. [PubMed: 16554073]
8. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide
synthase. J Biol Chem 1994;269:4705–4708. [PubMed: 7508926]
9. Lowenstein CJ, Alley EW, Raval P, et al. Macrophage nitric oxide synthase gene: two upstream regions
mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA
1993;90:9730–9734. [PubMed: 7692452]
10. Rice NR, Ernst MK. In vivo control of NF-κB activation by IκBα. EMBO (Eur Mol Biol Organ) J
1993;12:4685–4695.
Bhaskaran et al. Page 7
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

11. McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea
(Matricaria recutita L). Phytother Res 2006;20:519–530. [PubMed: 16628544]
12. Srivastava JK, Gupta S. Antiproliferative and Apoptotic Effects of Chamomile Extract in Various
Human Cancer Cells. J Agric Food Chem 2007;55:9470–9478. [PubMed: 17939735]
13. Speisky H, Rocco C, Carrasco C, Lissi EA, López-Alarcón C. Antioxidant screening of medicinal
herbal teas. Phytother Res 2006;20:462–467. [PubMed: 16619353]
14. Ganzera M, Schneider P, Stuppner H. Inhibitory effects of the essential oil of chamomile (Matricaria
recutita) and its major constituents on human cytochrome P450 enzymes. Life Sci 2006;78:856–861.
[PubMed: 16137701]
15. Ross SM. Chamomile: a spoonful of medicine. Holistic Nursing Practice 2008;22:56–57. [PubMed:
18172409]
16. Babenko NA, Shakhova EG. Effects of Chamomilla recutita flavonoids on age-related liver
sphingolipid turnover in rats. Exp Gerontol 2006;41:32–39. [PubMed: 16183236]
17. Lee KG, Shibamoto T. Determination of antioxidant potential of volatile extracts isolated from various
herbs and spices. J Agric Food Chem 2002;50:4947–4952. [PubMed: 12166987]
18. Srivastava, JK.; Gupta, S. Health promoting benefits of chamomile in the elderly population. In:
Watson, Ronald R., editor. Complementary and Alternative Therapies in the Aging Population.
Elsevier Inc., Academic Press; 2009.
19. Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-
inflammatory activity. Life Sci 2009;85:663–669. [PubMed: 19788894]
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein
utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254. [PubMed: 942051]
21. Shukla S, MacLennan GT, Fu P, et al. Nuclear Factor-κB/p65 (Rel A) Is Constitutively Activated in
Human Prostate Adenocarcinoma and Correlates with Disease Progression. Neoplasia 2004;6:390–
400. [PubMed: 15256061]
22. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol
1984;2:283–318. [PubMed: 6100475]
23. Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol
1994;56:576–582. [PubMed: 7525816]
24. Choi MS, Lee SH, Cho HS, et al. Inhibitory effect of obovatol on nitric oxide production and activation
of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol
2007;556:181–189. [PubMed: 17134693]
25. Park JS, Lee JH, Ha TY. Effects of capsaicin pretreatment on the function of mouse peritoneal
macrophages. Kor J Immunol 2000;22:39–49.
26. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of
nitric oxide synthase. J Biol Chem 1994;269:4705–4708. [PubMed: 7508926]
27. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor
promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/
cyclooxygenase homologue. J Biol Chem 1991;266:12866–12872. [PubMed: 1712772]
28. Lowenstein CJ, Alley EW, Raval P, et al. Macrophage nitric oxide synthase gene: two upstream
regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA
1993;90:9730–9734. [PubMed: 7692452]
29. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996;87:13–20. [PubMed: 8858144]
30. Zhou HY, Shin EM, Guo LY, et al. Anti-inflammatory activity of 4-methoxyhonokiol is a function
of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and
p38 MAPK inactivation. Eur J Pharmacol 2008;586:340–349. [PubMed: 18378223]
31. Ballard DW, Dixon EP, Peffer NJ, et al. The 65-kDa subunit of human NF-kB functions as a potent
transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA
1992;89:1875–1879. [PubMed: 1542686]
32. Schmitz ML, Baeuerle P. The p65 subunit is responsible for the strong transcription activating
potential of NF-kB. EMBO J 1991;10:3805–3817. [PubMed: 1935902]
Bhaskaran et al. Page 8
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

33. Vermeulen L, DeWilde G, Notebaert S, Vanden Berghe W, Haegeman G. Regulation of the
transcriptional activity of the nuclear factor kappaB p65 subunit. Biochem Pharmacol 2002;64:963–
970. [PubMed: 12213593]
34. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines
its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625–636. [PubMed: 11931769]
Bhaskaran et al. Page 9
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Figure 1.
(A) HPLC chromatogram of aqueous chamomile extract demonstrates apigenin 7-O-glucoside
as major constituent (B) standardization of chamomile extract with apigenin 7-O-glucoside
concentration (C) effect of chamomile on endogenous nitrite levels in culture medium of RAW
264.7 macrophages. Bars represent mean ± SEM of at least 3 independent experiments each
performed in triplicate **P<0.05 (ANOVA) and (D) effect of chamomile on cell viability as
determined by MTT assay and lower panel shows photograph of macrophages (a–d) after
treatment with 0, 10, 20 and 40 μg/mL chamomile extract. Details are described in ‘Materials
and methods’ section.
Bhaskaran et al. Page 10
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Figure 2.
Effect of chamomile on NO production in culture medium of RAW 264.7 cells (A) RAW 264.7
cells activated with 1μg/mL LPS (B) 1μg/mL IL-6, (C) 1μg/mL IL-1β , and (D) 1μg/mL
TNFα in the absence and presence of chamomile (10 and 20 μg/mL) for 16 h. Bars represent
mean ± SEM of at least 3 independent experiment each performed in triplicate, **P<0.001
(ANOVA), compared to LPS-challenge group. Details are described in ‘Materials and
methods’ section.
Bhaskaran et al. Page 11
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Figure 3.
Effect of chamomile on NO production in the culture medium of RAW 264.7 macrophages
(A) time-dependent effect using 1 μg/mL LPS in the absence and presence of 10 μg/mL
chamomile for indicated times. (B) dose-dependent effect using 1μg/mL LPS for 16 h in the
presence and absence of chamomile at indicated doses. L-NMMA (1 mM), a non-selective
inhibitor of all NOS isoforms was used as positive control. Bars represent mean ± SEM of at
least 3 independent experiments each performed in triplicate, **P<0.001 (ANOVA) compared
to LPS challenge group. Details are described in ‘Materials and methods’ section.
Bhaskaran et al. Page 12
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Figure 4.
Effect of chamomile on iNOS expression in RAW 264.7 macrophages. (A) Western blot for
iNOS protein expression, and (B) mRNA expression of iNOS in RAW 264.7 macrophages
stimulated with 1 μg/mL LPS and LPS and chamomile as indicated. Graph represents protein
and mRNA levels of iNOS corrected to the corresponding controls. L-NMMA, a non-selective
inhibitor of all NOS isoforms was used as positive control. Details are described in ‘Materials
and methods’ section.
Bhaskaran et al. Page 13
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript

Figure 5.
Effect of chamomile on NF-κ B activity. (A) Western blot analysis for protein expression of
p- IKKα /β , Iκ Bα and its phosphorylation, and RelA/p65 in the cytosolic fraction of RAW
264.7 macrophages stimulated with 1μg/mL LPS and LPS and chamomile for indicated doses,
(B) RelA/p65 expression in the nuclear fraction, (C) EMSA assay. EMSA was performed to
determine the effect of chamomile on the nuclear translocation of NF-κ B dimers and their
binding to DNA. Controls: #1 Biotin-EBNA control DNA, #2 Biotin-EBNA control DNA
+EBNA extract, #3 Biotin-EBNA control DNA + EBNA extract + 20-fold molar excess of
unlabeled EBNA DNA. L-NMMA, a non-selective inhibitor of all NOS isoforms was used as
positive control. The details are described in ‘Materials and Methods’ section.
Bhaskaran et al. Page 14
Int J Mol Med. Author manuscript; available in PMC 2010 December 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript